Filing Flows › Heartflow (HTFL) › Recalls, complaints & regulation
Heartflow (HTFL): clinical trials
Heartflow (HTFL) beyond its filings: 5 active clinical trials.
Heartflow's latest quarter
Heartflow, Q2 2026: revenue $64.1M (+48% year over year), operating margin -27.9%, net loss $15.7M, operating cash flow −$8.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Heartflow have?
5 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.